191 related articles for article (PubMed ID: 35760922)
1. Vascular involvement and resectability of pancreatic ductal adenocarcinoma on contrast-enhanced MRI: comparison with pancreatic protocol CT.
Noda Y; Kawai N; Kaga T; Ishihara T; Hyodo F; Kato H; Kambadakone AR; Matsuo M
Abdom Radiol (NY); 2022 Aug; 47(8):2835-2844. PubMed ID: 35760922
[TBL] [Abstract][Full Text] [Related]
2. Artificial intelligence for assessment of vascular involvement and tumor resectability on CT in patients with pancreatic cancer.
Bereska JI; Janssen BV; Nio CY; Kop MPM; Kazemier G; Busch OR; Struik F; Marquering HA; Stoker J; Besselink MG; Verpalen IM;
Eur Radiol Exp; 2024 Feb; 8(1):18. PubMed ID: 38342782
[TBL] [Abstract][Full Text] [Related]
3. Utility of Dark-Blood Dual-Energy CT Images for Predicting Vascular Involvement and R0 Resection in Patients With Pancreatic Cancer.
Si K; Wu H; Yang M; Guo Y; Zhang X; Ding C; Xue J; Han P; Li X
AJR Am J Roentgenol; 2023 Jun; 220(6):838-848. PubMed ID: 36541594
[No Abstract] [Full Text] [Related]
4. High-resolution pancreatic computed tomography for assessing pancreatic ductal adenocarcinoma resectability: a multicenter prospective study.
Lee DH; Ha HI; Jang JY; Lee JW; Choi JY; Bang S; Lee CH; Kim WB; Lee SS; Kim SC; Kang BK; Lee JM
Eur Radiol; 2023 Sep; 33(9):5965-5975. PubMed ID: 36988715
[TBL] [Abstract][Full Text] [Related]
5. Consensus in determining the resectability of locally progressed pancreatic ductal adenocarcinoma - results of the Conko-007 multicenter trial.
Wittel UA; Lubgan D; Ghadimi M; Belyaev O; Uhl W; Bechstein WO; Grützmann R; Hohenberger WM; Schmid A; Jacobasch L; Croner RS; Reinacher-Schick A; Hopt UT; Pirkl A; Oettle H; Fietkau R; Golcher H
BMC Cancer; 2019 Oct; 19(1):979. PubMed ID: 31640628
[TBL] [Abstract][Full Text] [Related]
6. Pancreas CT assessment for pancreatic ductal adenocarcinoma resectability: effect of tube voltage and slice thickness on image quality and diagnostic performance.
Lee DH; Lee SS; Lee JM; Choi JY; Lee CH; Ha HI; Kang BK; Yu MH; Chang W; Park SJ
Cancer Imaging; 2023 Dec; 23(1):126. PubMed ID: 38111054
[TBL] [Abstract][Full Text] [Related]
7. Post-neoadjuvant treatment pancreatic cancer resectability and outcome prediction using CT,
Yoo J; Lee JM; Joo I; Lee DH; Yoon JH; Yu MH; Jang JY; Lee SH
Cancer Imaging; 2023 May; 23(1):49. PubMed ID: 37217958
[TBL] [Abstract][Full Text] [Related]
8. Prediction of vascular involvement and resectability by multidetector-row CT versus MR imaging with MR angiography in patients who underwent surgery for resection of pancreatic ductal adenocarcinoma.
Lee JK; Kim AY; Kim PN; Lee MG; Ha HK
Eur J Radiol; 2010 Feb; 73(2):310-6. PubMed ID: 19070981
[TBL] [Abstract][Full Text] [Related]
9. Surgery after FOLFIRINOX treatment for locally advanced and borderline resectable pancreatic cancer: increase in tumour attenuation on CT correlates with R0 resection.
Marchegiani G; Todaro V; Boninsegna E; Negrelli R; Sureka B; Bonamini D; Salvia R; Manfredi R; Pozzi Mucelli R; Bassi C
Eur Radiol; 2018 Oct; 28(10):4265-4273. PubMed ID: 29679211
[TBL] [Abstract][Full Text] [Related]
10. Incremental Role of Pancreatic Magnetic Resonance Imaging after Staging Computed Tomography to Evaluate Patients with Pancreatic Ductal Adenocarcinoma.
Kim HJ; Park MS; Lee JY; Han K; Chung YE; Choi JY; Kim MJ; Kang CM
Cancer Res Treat; 2019 Jan; 51(1):24-33. PubMed ID: 29397657
[TBL] [Abstract][Full Text] [Related]
11. Preoperative CT Classification of the Resectability of Pancreatic Cancer: Interobserver Agreement.
Joo I; Lee JM; Lee ES; Son JY; Lee DH; Ahn SJ; Chang W; Lee SM; Kang HJ; Yang HK
Radiology; 2019 Nov; 293(2):343-349. PubMed ID: 31502935
[TBL] [Abstract][Full Text] [Related]
12. Adding Delayed Phase Images to Dual-Phase Contrast-Enhanced CT Increases Sensitivity for Small Pancreatic Ductal Adenocarcinoma.
Fukukura Y; Kumagae Y; Fujisaki Y; Yamagishi R; Nakamura S; Kamizono J; Nakajo M; Kamimura K; Nagano H; Takumi K; Yoshiura T
AJR Am J Roentgenol; 2021 Oct; 217(4):888-897. PubMed ID: 33759561
[No Abstract] [Full Text] [Related]
13. Preoperative evaluation of pancreatic cancer: comparison of gadolinium-enhanced dynamic MRI with MR cholangiopancreatography versus MDCT.
Park HS; Lee JM; Choi HK; Hong SH; Han JK; Choi BI
J Magn Reson Imaging; 2009 Sep; 30(3):586-95. PubMed ID: 19711405
[TBL] [Abstract][Full Text] [Related]
14. Determination of arterial invasion in pancreatic ductal adenocarcinoma: what is the best diagnostic criterion on CT?
Noda Y; Mizuno N; Kawai N; Ando T; Kawaguchi M; Nagata S; Fujimoto K; Nakamura F; Kaga T; Ishihara T; Hyodo F; Kato H; Kambadakone AR; Matsuo M
Eur Radiol; 2023 May; 33(5):3617-3626. PubMed ID: 36897348
[TBL] [Abstract][Full Text] [Related]
15. CT-determined resectability of borderline resectable and unresectable pancreatic adenocarcinoma following FOLFIRINOX therapy.
Jang JK; Byun JH; Kang JH; Son JH; Kim JH; Lee SS; Kim HJ; Yoo C; Kim KP; Hong SM; Seo DW; Kim SC; Lee MG
Eur Radiol; 2021 Feb; 31(2):813-823. PubMed ID: 32845389
[TBL] [Abstract][Full Text] [Related]
16. [MRI in the evaluation of peripancreatic vessel invasion and resectability of pancreatic carcinoma].
Wang DQ; Zeng MS; Jin DY; Lou WH; Ji Y; Rao SX; Shi X; Chen CZ; Li RC
Zhonghua Zhong Liu Za Zhi; 2007 Nov; 29(11):846-9. PubMed ID: 18396644
[TBL] [Abstract][Full Text] [Related]
17. Prediction of margin-negative resection of pancreatic ductal adenocarcinoma following neoadjuvant therapy: Diagnostic performance of NCCN criteria for resection vs CT-determined resectability.
Jang JK; Choi SJ; Byun JH; Kim JH; Lee SS; Kim HJ; Yoo C; Kim KP; Hong SM; Seo DW; Hwang DW; Kim SC
J Hepatobiliary Pancreat Sci; 2022 Sep; 29(9):1025-1034. PubMed ID: 35658103
[TBL] [Abstract][Full Text] [Related]
18. Applicability of current NCCN Guidelines for pancreatic adenocarcinoma resectability: analysis and pitfalls.
Garces-Descovich A; Beker K; Jaramillo-Cardoso A; James Moser A; Mortele KJ
Abdom Radiol (NY); 2018 Feb; 43(2):314-322. PubMed ID: 29392370
[TBL] [Abstract][Full Text] [Related]
19. Can we rely on contrast-enhanced CT to identify pancreatic ductal adenocarcinoma? A population-based study in sensitivity and factors associated with false negatives.
LeBlanc M; Kang J; Costa AF
Eur Radiol; 2023 Nov; 33(11):7656-7664. PubMed ID: 37266655
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic adenocarcinoma: variability in measurements of tumor size among computed tomography, magnetic resonance imaging, and pathologic specimens.
Ma C; Yang P; Li J; Bian Y; Wang L; Lu J
Abdom Radiol (NY); 2020 Mar; 45(3):782-788. PubMed ID: 31292672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
